Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions

Abstract

In a low gastric cancer incidence area, a surveillance programme can detect gastric cancer at an early curable stage with an overall risk of neoplastic progression of 0.3% per year. Use of serological markers in endoscopic surveillance programmes may improve risk stratification.